USD
+$0.00
(+0.00%
)At Close (As of Sep 8, 2025)
$3.17B
Market Cap
-
P/E Ratio
-3.88
EPS
$58.42
52 Week High
$32.47
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $871M |
Total Revenue | $1.3B |
Cost Of Revenue | $383M |
Costof Goods And Services Sold | $383M |
Operating Income | $129M |
Selling General And Administrative | $526M |
Research And Development | $183M |
Operating Expenses | $707M |
Investment Income Net | - |
Net Interest Income | -$33M |
Interest Income | $30M |
Interest Expense | $63M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $51M |
Income Before Tax | $88M |
Income Tax Expense | $25M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $63M |
Comprehensive Income Net Of Tax | - |
Ebit | $151M |
Ebitda | $203M |
Net Income | $63M |
Field | Value (USD) |
---|---|
Total Assets | $2.5B |
Total Current Assets | $1.1B |
Cash And Cash Equivalents At Carrying Value | $429M |
Cash And Short Term Investments | $429M |
Inventory | $148M |
Current Net Receivables | $224M |
Total Non Current Assets | $1.4B |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $237M |
Intangible Assets Excluding Goodwill | $237M |
Goodwill | $750M |
Investments | - |
Long Term Investments | $25M |
Short Term Investments | - |
Other Current Assets | $327M |
Other Non Current Assets | - |
Total Liabilities | $1.2B |
Total Current Liabilities | $392M |
Current Accounts Payable | $70M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $87M |
Total Non Current Liabilities | $794M |
Capital Lease Obligations | $49M |
Long Term Debt | $550M |
Current Long Term Debt | $78M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $677M |
Other Current Liabilities | $244M |
Other Non Current Liabilities | $129M |
Total Shareholder Equity | $1.3B |
Treasury Stock | - |
Retained Earnings | -$903M |
Common Stock | $83M |
Common Stock Shares Outstanding | $55M |
Field | Value (USD) |
---|---|
Operating Cashflow | $183M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $51M |
Capital Expenditures | $47M |
Change In Receivables | - |
Change In Inventory | -$6.8M |
Profit Loss | - |
Cashflow From Investment | -$48M |
Cashflow From Financing | $19M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | -$8.4M |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | $63M |
Field | Value (USD) |
---|---|
Gross Profit | $871M |
Total Revenue | $1.3B |
Cost Of Revenue | $383M |
Costof Goods And Services Sold | $383M |
Operating Income | $129M |
Selling General And Administrative | $526M |
Research And Development | $183M |
Operating Expenses | $707M |
Investment Income Net | - |
Net Interest Income | -$33M |
Interest Income | $30M |
Interest Expense | $63M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $51M |
Income Before Tax | $88M |
Income Tax Expense | $25M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $63M |
Comprehensive Income Net Of Tax | - |
Ebit | $151M |
Ebitda | $203M |
Net Income | $63M |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
LivaNova PLC, a medical device company, designs, develops, manufactures and sells therapeutic solutions globally. The company is headquartered in London, the United Kingdom.